Life-altering gene transfer therapies for serious disorders of the brain and central nervous system, including Parkinson’s disease, Epilepsy and Huntington’s chorea.
Recent News
Neurologix Announces Q1 2009 Financial Results More

Neurologix to Present at The Neurotech Industry Investing and Partnering Conference 2009 More

Neurologix Announces Year End 2008 Results More
CLINICAL TRIALS
Learn more
© 2009 Neurologix, Inc. Site Map Terms Site design: Schenkel/Stegman